Daptomycin for Children in Clinical Practice Experience
Authors:
- Silvia GarazzinoSGSilvia Garazzino
- Elio CastagnolaECElio Castagnola
- Maria Di GangiMGMaria Di Gangi
- Rita OrtolanoRORita Ortolano
- Andrzej KrzysztofiakAKAndrzej Krzysztofiak
- Agostino NocerinoANAgostino Nocerino
- Susanna EspositoSusanna Esposito
- Patrizia D’aRgenioPDPatrizia D’aRgenio
- Luisa GalliLGLuisa Galli
- Giuseppe LosurdoGLGiuseppe Losurdo
- Carmelina CalitriCCCarmelina Calitri
- Pier-Angelo TovoPTPier-Angelo Tovo
- 1 June 2016
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 35 (6) , 639-641
Abstract
Data on daptomycin use in the pediatric setting are scanty. We conducted a multicenter, retrospective study on 46 children treated with intravenous daptomycin at a mean dosage of 7.0 mg/kg/d, for a median of 14 days. Three children had adverse events possibly related to daptomycin. The drug was overall well tolerated, even with prolonged treatment.Keywords
This publication has 6 references indexed in Scilit:
- Daptomycin in paediatrics: current knowledge and the need for future researchJournal of Antimicrobial Chemotherapy, 2014
- Safety of daptomycin in patients completing more than 14 days of therapy: results from the Cubicin® Outcomes Registry and ExperienceInternational Journal of Antimicrobial Agents, 2013
- Single-dose Pharmacokinetics and Tolerability of Daptomycin 8 to 10 mg/kg in Children Aged 2 to 6 Years With Suspected or Proved Gram-positive InfectionsThe Pediatric Infectious Disease Journal, 2011
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive SummaryClinical Infectious Diseases, 2011
- Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteriaClinical Microbiology and Infection, 2006